Healthcare Contract Research Outsourcing Market, By Services Type (Clinical Trials (Drug Discovery, Preclinical, Phase I, Phase II, Phase III, Phase IV)), Regulatory Services, Medical Writing, Clinical Data Management, and Others), By End User (CROs, Clinical Trial Laboratories, and AMCs), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East and Africa) -

Published In : Jul 2023

Code : CMI3788

Pages :145

Formats :

Excel and PDF

Industry : Pharmaceutical

Market News

Global Healthcare Contract Research Outsourcing Market: Key Developments

In March 2020, Medpace Holdings, Inc., a healthcare CRO, partnered with Medidata Solutions, a service company, to integrate its imaging systems and workflow with Medidata Rave imaging for clinical trials.

In April 2020, IQVIA, Inc. launched its new technology-enabled COVID-19 Trial Matching Tool at c19trials.com, which is an online platforms that matches individuals with specific COVID-19 studies to accelerate clinical research projects.

In November, 2021, Inotiv, a accompany that provides non-clinical and analytical drug discovery and development services, research models, and related products and services, completed the acquisition of Envigo, a London-based a privately-held contract research organization and laboratory animal source, to help bring new drugs and medical devices through the discovery and preclinical phases of development.

In April 2021, IQVIA Inc,- a global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry, announced the acquisition of Q2 Solutions from Quest Diagnostics, a U.S-based clinical laboratory.

Global Healthcare Contract Research Outsourcing Market: Key Trends

On April 17, 2023, PHARMALEX GMBH, a Germany-based pharmaceutical consulting company that provides specialized services for the pharmaceutical, biotechnology, and medical devices, announced a merger with Cpharm Australia, a provider of pharmacovigilance services in Australia and New Zealand, to expand the company’s footprint in Australia.

On June 15 2023, Koneksa Health, an evidence-based digital biomarkers company, announced a partnership with Beacon Biosignals, a computational neurodiagnostics company, to launch a clinical trial to investigate the integration of Beacon’s at-home Electroencephalogram (EEG) into the Koneksa Neuroscience Solution Toolkit. The Koneksa-sponsored clinical validation study is an observational study that discovers biomarkers and determines the usability and validity of measures of sleep and neurologic disorders collected using at-home wearables, and smartphones.